Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEV-50717 (Deutetrabenazine) for Dyskinesia in Cerebral Palsy in Children and Adolescents
2018-003742-17Phase 3Unknown
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dyskinesia and dyskinetic cerebral palsy (DCP) comparing TEV-50717 (deutetrabenazine) with Placebo (2 arms). Status: unknown.
02
Drugs
deutetrabenazine
03
Conditions
dyskinesiadyskinetic cerebral palsy (DCP)
Beyond the preview
Go deeper on 2018-003742-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003742-17.